Andrew J. Murphy serves as Executive at REGENERON PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Andrew J. Murphy has executed 257 insider transactions totaling $57.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 27, 2020 involved selling 1,355 shares valued at $461.5K.
Andrew J. Murphy currently holds 47,833 shares of REGENERON PHARMACEUTICALS, INC. (REGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew J. Murphy has been a net seller of REGN stock. They have purchased $0 and sold $57.6M worth of shares.
Andrew J. Murphy's most recent insider trade was on Jan 27, 2020, when they sold 1,355 shares at $340.56 per share.
Get notified when new Form 4 filings are submitted
| $343.02 |
| Discretionary |
| Jan 27, 2020 | REGN | $241.0K | Sale | 712 | $338.54 | Discretionary |
| Jan 27, 2020 | REGN | $91.1K | Sale | 270 | $337.46 | Discretionary |
| Jan 27, 2020 | REGN | $67.4K | Sale | 200 | $336.78 | Discretionary |
| Dec 11, 2019 | REGN | $0 | Award | 2,625 | $N/A | Discretionary |
| Dec 11, 2019 | REGN | $0 | Award | 10,000 | $N/A | Discretionary |